Resmed RMD
NYSE RMD
$224.99 -3.51 (-1.54%)
At close: Sep 18, 2026 · 4:00 PM EDT

Resmed (RMD) Operating Margin Growth (3y) (2012 - 2026)

Analysis

Resmed (RMD) Operating Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn -201.00
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn 722.00
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn 162.00
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn 586.00
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn 736.00
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn 887.00
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn 963.00
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn 612.00
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn -1,075.00
10 Steris 20.01 Bn 19.54 Bn 684.20 Mn 244.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 612.00
Mar 31, 2026 800.00
Dec 31, 2025 745.00
Sep 30, 2025 442.00
Jun 30, 2025 580.00
Mar 31, 2025 590.00
Dec 31, 2024 475.00
Sep 30, 2024 266.00
Jun 30, 2024 358.00
Mar 31, 2024 223.00
Dec 31, 2023 -406.00
Sep 30, 2023 -263.00
Jun 30, 2023 -445.00
Mar 31, 2023 -135.00
Dec 31, 2022 23.00
Sep 30, 2022 389.00
Jun 30, 2022 1,075.00
Mar 31, 2022 339.00
Dec 31, 2021 367.00
Sep 30, 2021 447.00